Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Brain : a journal of neurology

• Publication date

  2016-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/brain/aww016PMID 26921617PMCID PMC5006229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Depletion of microglia and inhibition of exosome synthesis halt tau propagation

  2015cited by this paper
• Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.

  2015cited by this paper
• Astrocyte Depletion Impairs Redox Homeostasis and Triggers Neuronal Loss in the Adult CNS.

  2015cited by this paper
• Characterizing Newly Repopulated Microglia in the Adult Mouse: Impacts on Animal Behavior, Cell Morphology, and Neuroinflammation

  2015cited by this paper
• Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.

  2015cited by this paper
• α-TLR2 antibody attenuates the Aβ-mediated inflammatory response in microglia through enhanced expression of SIGIRR.

  2015cited by this paper
• TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model

  2015cited by this paper
• Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice

  2015influential reference
• Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model

  2015cited by this paper
• Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models.

  2015cited by this paper
• Cerebral adrenoleukodystrophy: a demyelinating disease that leaves the door wide

  2015cited by this paper
• Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology.

  2015cited by this paper
• Arginine Deprivation and Immune Suppression in a Mouse Model of Alzheimer's Disease

  2015cited by this paper
• Elimination of Microglia Improves Functional Outcomes Following Extensive Neuronal Loss in the Hippocampus

  2015cited by this paper
• IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior.

  2015cited by this paper
• TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models

  2015cited by this paper
• Age-related downregulation of the CaV3.1 T-type calcium channel as a mediator of amyloid beta production.

  2014cited by this paper
• Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques

  2014cited by this paper
• Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function.

  2014influential reference
• Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.

  2014cited by this paper
• Review: The genetics of Alzheimer's disease; putting flesh on the bones

  2014cited by this paper
• Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain.

  2014influential reference
• Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.

  2014cited by this paper
• Hippocampal Adaptive Response Following Extensive Neuronal Loss in an Inducible Transgenic Mouse Model

  2014cited by this paper
• Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor

  2014cited by this paper
• CD33 Alzheimer’s disease locus: Altered monocyte function and amyloid biology

  2013influential reference
• Deletion of Abca7 Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease

  2013cited by this paper
• Regulation of Microglial Proliferation during Chronic Neurodegeneration

  2013cited by this paper
• Identification of a Unique TGF-β Dependent Molecular and Functional Signature in Microglia

  2013influential reference
• Synaptic deficits in layer 5 neurons precede overt structural decay in 5xFAD mice.

  2013influential reference
• Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation

  2013influential reference
• Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology

  2013influential reference
• Spine pruning in 5xFAD mice starts on basal dendrites of layer 5 pyramidal neurons

  2013cited by this paper
• Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.

  2013cited by this paper
• CD2-Associated Protein Regulates Plasmacytoid Dendritic Cell Migration, but Is Dispensable for Their Development and Cytokine Production

  2013cited by this paper
• CSF-1R inhibition alters macrophage polarization and blocks glioma progression

  2013cited by this paper
• Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer’s brains

  2013cited by this paper
• TREM2 variants in Alzheimer's disease.

  2013influential reference
• Blockage of CR1 prevents activation of rodent microglia.

  2013influential reference
• Microglial Stimulation of Glioblastoma Invasion Involves Epidermal Growth Factor Receptor (EGFR) and Colony Stimulating Factor 1 Receptor (CSF-1R) Signaling

  2012cited by this paper
• PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts.

  2012influential reference
• PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice

  2012cited by this paper
• Early intervention with a small molecule inhibitor for tumor nefosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer’s disease

  2012cited by this paper
• Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease.

  2012cited by this paper
• Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer’s Disease Model

  2011cited by this paper
• Presenilin Is Necessary for Efficient Proteolysis through the Autophagy–Lysosome System in a γ-Secretase-Independent Manner

  2011cited by this paper
• Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease

  2011influential reference
• Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease

  2011cited by this paper
• Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE

  2010cited by this paper
• Reductions in Amyloid-β-Derived Neuroinflammation, with Minocycline, Restore Cognition but do not Significantly Affect Tau Hyperphosphorylation

  2010cited by this paper
• CNS expression of anti‐inflammatory cytokine interleukin‐4 attenuates Alzheimer's disease‐like pathogenesis in APP+PS1 bigenic mice

  2010cited by this paper
• Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease

  2010cited by this paper
• Formation and maintenance of Alzheimer’s disease beta-amyloid plaques in the absence of microglia

  2010cited by this paper
• Genome-wide analysis of genetic loci associated with Alzheimer disease.

  2010influential reference
• Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia

  2009cited by this paper
• Resting Microglia Directly Monitor the Functional State of Synapses In Vivo and Determine the Fate of Ischemic Terminals

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• Inflammation Triggers Synaptic Alteration and Degeneration in Experimental Autoimmune Encephalomyelitis

  2009cited by this paper
• Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

  2009cited by this paper
• Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.

  2008cited by this paper
• Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model.

  2007cited by this paper
• In Brief

  2007influential reference
• Long-term two-photon transcranial imaging of synaptic structures in the living brain.

  2007cited by this paper
• Spatial relationship between synapse loss and β‐amyloid deposition in Tg2576 mice

  2007cited by this paper
• Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.

  2006cited by this paper
• Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

  2006influential reference
• Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease

  2005cited by this paper
• Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease

  2005cited by this paper
• Microglial Phagocytosis Induced by Fibrillar β-Amyloid and IgGs Are Differentially Regulated by Proinflammatory Cytokines

  2005cited by this paper
• Cytokines in neuroinflammation and Alzheimer's disease.

  2004cited by this paper
• Microglia in cerebellar plaques in Alzheimer's disease

  2004cited by this paper
• Displacement of synaptic terminals from regenerating motoneurons by microglial cells

  2004cited by this paper
• Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses.

  2002cited by this paper
• In-vivo measurement of activated microglia in dementia.

  2001cited by this paper
• Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease

  2001cited by this paper
• Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice.

  2001cited by this paper
• Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice

  2001cited by this paper
• β-Amyloid Stimulation of Inducible Nitric-oxide Synthase in Astrocytes Is Interleukin-1β- and Tumor Necrosis Factor-α (TNFα)-dependent, and Involves a TNFα Receptor-associated Factor- and NFκB-inducing Kinase-dependent Signaling Mechanism*

  2000cited by this paper
• Isolation and Characterization of Apolipoproteins from Murine Microglia

  2000cited by this paper
• Cell mediators of inflammation in the Alzheimer disease brain.

  2000cited by this paper
• Estrogen Enhances Uptake of Amyloid β‐Protein by Microglia Derived from the Human Cortex

  2000cited by this paper
• Complement component C1q modulates the phagocytosis of Abeta by microglia.

  2000cited by this paper
• Brain inflammation in Alzheimer disease and the therapeutic implications.

  1999cited by this paper
• Identification of monocyte chemoattractant protein‐1 in senile plaques and reactive microglia of Alzheimer's disease

  1997cited by this paper
• Activation of microglial cells by beta-amyloid protein and interferon-gamma.

  1995cited by this paper
• Elevated circulating tumor necrosis factor levels in Alzheimer's disease.

  1991cited by this paper
• Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

  1988cited by this paper
• Role of microglia in plaque formation in senile dementia of the Alzheimer type

  1986cited by this paper
• The small pyramidal neuron of the rat cerebral cortex. The perikaryon, dendrites and spines.

  1970influential reference

• Microglia-Neuron Crosstalk: An Intimate Molecular Conversation in Neurodegeneration.

  2026cites this paper
• Dynamics and Impact of Repopulating Microglia Following Oligodendroglial Damage

  2026cites this paper
• Functional border-associated macrophages limit Alzheimer’s Disease progression

  2026cites this paper
• KCC2 Dysfunction Mediated by Microglial BDNF/TrkB Signaling Exacerbates Early Post‐Stroke Seizure Susceptibility

  2026cites this paper
• iPSC-Derived Microglia: Decoding Roles and Therapeutic Opportunities in Neurodegenerative Diseases.

  2026cites this paper
• The impact of CSF1R inhibitor-mediated microglial depletion in rodent models of Alzheimer’s and Parkinson’s disease: a systematic review and meta-analysis

  2026cites this paper
• Microglia replacement by peripheral delivery of CSF1R inhibitor-resistant hematopoietic cells.

  2025cites this paper
• Alzheimer’s disease risk ABCA7 p.A696S variant disturbs the microglial response to amyloid pathology in mice

  2025cites this paper
• Repurposing immunomodulatory drugs targeting microglia for amyotrophic lateral sclerosis.

  2025cites this paper
• How the gut microbiota impacts neurodegenerative diseases by modulating CNS immune cells

  2025cites this paper
• Pathogenesis and therapeutic applications of microglia receptors in Alzheimer’s disease

  2025cites this paper
• The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice

  2025cites this paper
• Novel perspective on particulate matter and Alzheimer's disease: Insights from adverse outcome pathway framework.

  2025cites this paper
• Microglia-Mediated Phagocytosis in Alzheimer’s Disease: Mechanisms, Heterogeneity, and Therapeutic Insights

  2025cites this paper
• Pharmacological Inhibition of Microglial Proliferation Supports Blood–Brain Barrier Integrity in Experimental Autoimmune Encephalomyelitis

  2025cites this paper
• Comparative analysis of neuroinflammatory pathways in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis: insights into similarities and distinctions

  2025cites this paper
• Cytokine–Microglia Interactions in Neuroinflammation: Mechanisms, Disease Dynamics, and Therapeutic Strategies

  2025cites this paper
• Generation and characterization of a tamoxifen-inducible, Cre driver rat for transgene expression in microglia

  2025cites this paper
• Generation of an Inducible Destabilized‐Domain Cre Mouse Line to Target Disease Associated Microglia

  2025cites this paper
• Evaluation of in-vivo and in-vitro binding property of a novel PET tracer for CSF1R imaging and comparison with two currently-used CSF1R-PET tracers

  2025cites this paper
• Plant‐Based Therapies to Ameliorate Neuroinflammation in Parkinson's Disease, Alzheimer's Disease, and Epilepsy: A Narrative Review

  2025cites this paper
• Microglia heterogeneity, modeling and cell-state annotation in development and neurodegeneration

  2025cites this paper
• Exploring microglial replacement: From disease models to clinical translation.

  2025cites this paper
• RIC-specific cytoprotective profile mediated by microglia in a mouse model of acute ischaemic stroke

  2025cites this paper
• Microglial clearance, neuroprotection and cognitive recovery via a novel synthetic sulfolipid in Alzheimer’s disease

  2025cites this paper
• Microglial activation as a hallmark of neuroinflammation in Alzheimer’s disease

  2025cites this paper
• Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by α-synuclein overexpression

  2025cites this paper
• Recent advances in colony stimulating factor-1 receptor (CSF1R) inhibitors.

  2025cites this paper
• Mouse-to-human modeling of microglia single-nuclei transcriptomics identifies immune signaling pathways and potential therapeutic candidates associated with Alzheimer’s disease

  2025cites this paper
• Satellite microglia: marker of traumatic brain injury and regulator of neuronal excitability

  2025cites this paper
• Microglia across evolution: from conserved origins to functional divergence

  2025cites this paper
• TLR4 Inhibition Attenuate Facilitatory Effects of JQ1 on Learning & Memory Via Polarization of Microglia, and BDNF Expression in Alzheimer's Disease Model.

  2025cites this paper
• Microglial phagocytosis in Alzheimer disease

  2025cites this paper
• Soluble CSF1R promotes microglial activation and amyloid clearance in alzheimer’s disease

  2025cites this paper
• Evolving insights into the identity and function of dark microglia.

  2025cites this paper
• Characterizing Microglial Signaling Dynamics During Inflammation Using Single‐Cell Mass Cytometry

  2025cites this paper
• Searching for the cellular underpinnings of the selective vulnerability to tauopathic insults in Alzheimer’s disease

  2025cites this paper
• The paradoxical protective effect of chronic stress on advanced Alzheimer's disease pathology.

  2025cites this paper
• Neural stem cell-derived small extracellular vesicles: a new therapy approach in neurological diseases

  2025cites this paper
• Transcriptomic Analysis Divulges Differential Expressions of Microglial Genes After Microglial Repopulation in Mice

  2025cites this paper
• Microglia-specific regulation of lipid metabolism in Alzheimer’s disease revealed by microglial depletion in 5xFAD Mice

  2025cites this paper
• Circular RNA aptamers targeting neuroinflammation ameliorate Alzheimer disease phenotypes in mouse models.

  2025cites this paper
• Development of cerebral microhemorrhages in a mouse model of hypertension

  2025cites this paper
• The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration

  2025cites this paper
• Clec7a Signaling in Microglia Promotes Synapse Loss Associated with Tauopathy

  2025cites this paper
• Repair-associated macrophages increase after early-phase microglia attenuation to promote ischemic stroke recovery

  2025cites this paper
• Genetic convergence in brain aging and neurodegeneration: from cellular mechanisms to therapeutic targets

  2025cites this paper
• A 3D human iPSC-derived multi-cell type neurosphere system to model cellular responses to chronic amyloidosis

  2025cites this paper
• Identification of key genes and regulatory networks associated with atherosclerotic carotid artery stenosis through comprehensive bioinformatics analysis and machine learning

  2025cites this paper
• Microglial phagoptosis in development, health, and disease.

  2025cites this paper
• Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation

  2025cites this paper
• The Spectrum of Microglia: Decoding Heterogeneity and Plasticity for Therapeutic Gain in Neurological Disorders

  2025cites this paper
• Microglia transcriptional states and their functional significance: Context drives diversity.

  2025cites this paper
• Evaluation of in vivo and in vitro binding property of a novel candidate PET tracer for CSF1R imaging and comparison with two currently-used CSF1R-PET tracers

  2025cites this paper
• Systemic inflammation as a central player in the initiation and development of Alzheimer’s disease

  2025cites this paper
• DP1 Receptor Blockade Attenuates Microglial Senescence and Cognitive Decline Caused by PTGDS in Exosomes From Aged Brains

  2025cites this paper
• Long-term Nrf2-driven microglial repopulation mitigates microgliosis, neuronal loss and cognitive deficits in tauopathy

  2025cites this paper
• Response of spatially defined microglia states with distinct chromatin accessibility in a mouse model of Alzheimer’s disease

  2025cites this paper
• Repopulation of microglia and its implications for CNS disorders: Insights from the single-cell era.

  2025cites this paper
• Targeting glial dysfunction in Alzheimer’s disease: insights into pathogenesis and emerging therapeutics

  2025cites this paper
• Neuroinflammation across the Spectrum of Neurodegenerative Diseases: Mechanisms and Therapeutic Frontiers

  2025cites this paper
• MS4A6A/Ms4a6d deficiency disrupts neuroprotective microglia functions and promotes inflammation in Alzheimer’s disease model

  2025cites this paper
• A multimodal approach of microglial CSF1R inhibition and GENUS provides therapeutic effects in Alzheimer’s disease mice

  2025cites this paper
• S‐9‐PAHSA Attenuates Aβ Accumulation and Improves Cognitive Deficits by Promoting Mitochondrial Autophagy in 5xFAD Mice

  2025cites this paper
• Comparison of microglial cell population expansion in the Tg344-AD rat and APPSWE/PS1ΔE9 mouse model of Alzheimer's disease

  2025cites this paper
• Dual immune modulation of microglia in viral encephalitis: current understanding and future perspectives

  2025cites this paper
• Evolutionary sex bias in cognitive response to new environmental risk factor - PM2.5

  2025cites this paper
• Inhibiting the Cholesterol Storage Enzyme ACAT1/SOAT1 in Myelin Debris-Treated Microglial Cell Lines Activates the Gene Expression of Cholesterol Efflux Transporter ABCA1

  2024cites this paper
• Apolipoprotein E aggregation in microglia initiates Alzheimer's disease pathology by seeding β-amyloidosis.

  2024cites this paper
• Continuous theta burst stimulation ameliorates cognitive deficits in microinfarcts mice via inhibiting glial activation and promoting paravascular CSF-ISF exchange.

  2024cites this paper
• Generation of an inducible destabilized-domain Cre mouse line to target disease associated microglia

  2024cites this paper
• The intricate interplay between microglia and adult neurogenesis in Alzheimer’s disease

  2024cites this paper
• Border-associated macrophages: From physiology to therapeutic targets in Alzheimer's disease.

  2024cites this paper
• Contactomics of Microglia and Intercellular Communication.

  2024cites this paper
• Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States

  2024cites this paper
• Microglia either promote or restrain TRAIL-mediated excitotoxicity caused by Aβ1−42 oligomers

  2024cites this paper
• Characterizing microglial signaling dynamics during inflammation using single-cell mass cytometry

  2024cites this paper
• Microglia Signaling in Health and Disease - Implications in Sex-Specific Brain Development and Plasticity.

  2024cites this paper
• Microglia initially seed and later reshape amyloid plaques in Alzheimer’s disease

  2024cites this paper
• Targeting Microglia in Alzheimer’s Disease: Pathogenesis and Potential Therapeutic Strategies

  2024cites this paper
• The Effect of Pexidartinib on Neuropathic Pain via Influences on Microglia and Neuroinflammation in Mice.

  2024cites this paper
• Amyloid-β-activated microglia can induce compound proteinopathies.

  2024cites this paper
• Synergism of ApoE4 and systemic infectious burden is mediated by the APOE‐NLRP3 axis in Alzheimer's disease

  2024cites this paper
• Targeting the NLRP3 inflammasome in cochlear macrophages protects against hearing loss in chronic suppurative otitis media

  2024cites this paper
• Essential Oil Constituents as Anti-Inflammatory and Neuroprotective Agents: An Insight through Microglia Modulation

  2024cites this paper
• Selective targeting and modulation of plaque associated microglia via systemic hydroxyl dendrimer administration in an Alzheimer’s disease mouse model

  2024cites this paper
• Brain-specific targeted delivery of therapeutic agents using metal–organic framework-based nanomedicine

  2024cites this paper
• Ovariectomy and High Fat-Sugar-Salt Diet Induced Alzheimer's Disease/Vascular Dementia Features in Mice

  2024influential citation
• Circular RNA aptamers ameliorate AD-relevant phenotypes by targeting PKR

  2024cites this paper
• Aging, sex, metabolic and life experience factors: contributions to neuro-inflammaging in Alzheimer's disease research.

  2024cites this paper
• Blocking Microglial Proliferation by CSF-1R Inhibitor Does Not Alter the Neuroprotective Effects of Adoptive Regulatory T Cells in 3xTg Alzheimer’s Disease Mice

  2024cites this paper
• Microglia and amyloid plaque formation in Alzheimer's disease - Evidence, possible mechanisms, and future challenges.

  2024cites this paper
• Targeting aberrant glycosylation to modulate microglial response and improve cognition in models of Alzheimer's disease.

  2024cites this paper
• A M1 muscarinic acetylcholine receptor-specific positive allosteric modulator VU0486846 reduces neurogliosis in female Alzheimer's mice.

  2024cites this paper
• Potential Alzheimer’s disease drug targets identified through microglial biology research

  2024cites this paper
• The changes of neurogenesis in the hippocampal dentate gyrus of SAMP8 mice and the effects of acupuncture and moxibustion.

  2024cites this paper
• Immune Activation in Alzheimer Disease.

  2024cites this paper
• Strategies to dissect microglia-synaptic interactions during aging and in Alzheimer's disease.

  2024cites this paper
• Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway

  2024cites this paper
• Colony Stimulating Factor-1 Receptor: An emerging target for neuroinflammation PET imaging and AD therapy.

  2024cites this paper